Shay Capital LLC Mereo Biopharma Group PLC Transaction History

Shay Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.04 - $1.7 $49,974 - $81,688	-48,052 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.51 - $2.59 $72,558 - $124,454	48,052 New	48,052 $77,000
Q3 2021 Nov 15, 2021	SELL	$2.2 - $3.17 $27,909 - $40,214	-12,686 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$2.94 - $4.08 $13,468 - $18,690	-4,581 Reduced 26.53%	12,686 $40,000
Q1 2021 Aug 13, 2021	SELL	$2.6 - $4.43 $386,214 - $658,049	-148,544 Reduced 89.59%	17,267 $58,000
Q4 2020 Aug 13, 2021	BUY	$1.95 - $3.6 $323,331 - $596,919	165,811 New	165,811 $594,000

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $465M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Shay Capital LLC with notifications on news.